© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filing Details
Document Details
Form
Filing Date
Feb 22, 2021
Document Date
Feb 18, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intra-Cellular Therapies Inc.
Issuer
INTRA-CELLULAR THERAPIES, INC.
Filer
Neumann Mark